Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Blondeau

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
Expert Review of Clinical Pharmacology|December 7, 2011
Macrocyclic antibiotics: a novel class of drug for the treatment of Clostridium difficile infectionJoseph M Blondeau
Future Microbiology|November 6, 2020
Clinical microbiology laboratories and COVID-19: the calm before the stormJoseph M Blondeau
Expert Opinion on Pharmacotherapy|August 2, 2002
The evolution and role of macrolides in infectious diseasesJoseph M Blondeau
Expert Review of Respiratory Medicine|December 22, 2017
Targeted drug delivery and drug resistant pathogensJoseph M Blondeau
Future Microbiology|June 13, 2017
Antimicrobial resistance & 'Man's best friend': what they give to us we might be giving right backJoseph M Blondeau
Drugs|March 17, 2004
Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment optionJoseph M Blondeau
Veterinary Dermatology|February 25, 2010
New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approachJoseph M Blondeau
Clinical Therapeutics|March 25, 1999
Expanded activity and utility of the new fluoroquinolones: a reviewJ M Blondeau
Expert Opinion on Investigational Drugs|November 4, 2000
Gatifloxacin: a new fluoroquinoloneJ M Blondeau
Expert Review of Respiratory Medicine|December 3, 2024
Long COVID: a consequence of chronic post-infectious inflammation!Joseph M Blondeau
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
Expert Review of Clinical Pharmacology|December 7, 2011
Macrocyclic antibiotics: a novel class of drug for the treatment of Clostridium difficile infectionJoseph M Blondeau
Future Microbiology|November 6, 2020
Clinical microbiology laboratories and COVID-19: the calm before the stormJoseph M Blondeau
Expert Opinion on Pharmacotherapy|August 2, 2002
The evolution and role of macrolides in infectious diseasesJoseph M Blondeau
Expert Review of Respiratory Medicine|December 22, 2017
Targeted drug delivery and drug resistant pathogensJoseph M Blondeau
Future Microbiology|June 13, 2017
Antimicrobial resistance & 'Man's best friend': what they give to us we might be giving right backJoseph M Blondeau
Drugs|March 17, 2004
Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment optionJoseph M Blondeau
Veterinary Dermatology|February 25, 2010
New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approachJoseph M Blondeau
Clinical Therapeutics|March 25, 1999
Expanded activity and utility of the new fluoroquinolones: a reviewJ M Blondeau
Expert Opinion on Investigational Drugs|November 4, 2000
Gatifloxacin: a new fluoroquinoloneJ M Blondeau
Expert Review of Respiratory Medicine|December 3, 2024
Long COVID: a consequence of chronic post-infectious inflammation!Joseph M Blondeau
Pageof 16